✦ LIBER ✦
Pharmacodynamic monitoring of BAY 43-9006 (Sorafenib) in phase I clinical trials involving solid tumor and AML/MDS patients, using flow cytometry to monitor activation of the ERK pathway in peripheral blood cells
✍ Scribed by Frances K. Tong; Sue Chow; David Hedley
- Publisher
- John Wiley and Sons
- Year
- 2006
- Tongue
- English
- Weight
- 374 KB
- Volume
- 70B
- Category
- Article
- ISSN
- 1552-4949
No coin nor oath required. For personal study only.